Edwards Lifesciences Corp. has agreed to pay a six-figure sum plus royalties to Abbott Laboratories to settle claims Edwards infringed on Abbott-held patents on transcatheter mitral and tricuspid repair products.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?